Overview

A Study of the Safety and How the Body Affects a Drug (CNTO 1959) in Healthy Volunteers and in Patients With Psoriasis

Status:
Completed

Trial end date:
2010-10-11

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety and how the body affects a drug (CNTO 1959) in healthy volunteers and in patients with psoriasis.

Phase:

Phase 1

Details

Lead Sponsor:

Centocor, Inc.